Actinium KOL Joseph Jurcic, MD to Discuss the Role of Actiniumâs Alpha-Particle Radiopharmaceuticals in the Treatment of Leukemia Patients at the 2014 Society of Nuclear Medicine and Molecular Imaging Annual Meeting